Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009
Allergic inflammation markers for earlier diagnosis of bronchial asthma in patients with allergic rhinitis Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008
Iron in serum and induced sputum of patients with allergic rhinitis and allergic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006
Allergic rhinitis co-morbidity as risk factor on lung function parameters recovery after asthma exacerbation Source: International Congress 2019 – Epidemiology of childhood respiratory diseases Year: 2019
Variants of allergic response in children with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 162s Year: 2004
Zinc in serum and induced sputum of patients with allergic rhinitis and allergic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 353s Year: 2004
Inflammatory profile of patients with allergic asthma & rhinitis versus patients with allergic rhinitis alone Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients Year: 2007
Treatment and outcomes in patients with asthma and allergic rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 576s Year: 2005
IL-33 in patients with severe uncontrolled allergic asthma Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017
Role of neutrophils in maintenance of severity of non-allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 585s Year: 2007
Improvements in asthma control and quality of life with omalizumab in allergic (IgE-mediated) asthma patients Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012
Incidence of allergic asthma in patients with sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 232s Year: 2006
Prognosis of allergic and non-allergic asthma Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012
Immunotherapy prevents the development of asthma in subjects with allergic rhinitis Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001
Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011
Persistency of treatment response to omalizumab in patients with severe allergic (IgE-mediated) asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Local cytokine profile specifics among patients with BA phenotype, associated to allergic rhinitis: allergic rhinitis and bronchial asthma. Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018
Changes in lung functions and inflammatory markers in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens Source: Eur Respir J 2005; 26: Suppl. 49, 734s Year: 2005
Investigation for atopy in families of children with allergic bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 254s Year: 2006
NTPDase activity in circulatory eosinophils from patients with allergic asthma Source: International Congress 2017 – New immune markers for asthma and COPD Year: 2017